Table 5

Baseline characteristics of the propensity score-matched cohort (n=100), according to the use of thoracic epidural analgesia

Thoracic epidural analgesiap Value
NoYes
n=50n=50
Age, years80±978±80.281
Males22 (44.0)18 (36.0)0.541
Diabetes17 (34.0)19 (38.0)0.835
Dyslipidemia42 (84.0)43 (86.0)1.00
Hypertension47 (94.0)47 (94.0)1.00
Coronary artery disease33 (66.0)35 (70.0)0.831
Previous myocardial infarction23 (46.0)21 (42.0)0.841
Previous atrial fibrillation15 (30.0)13 (26.0)0.824
Prior CABG21 (42.0)18 (36.0)0.682
Prior stroke2 (4.0)4 (8.0)0.678
Peripheral vascular disease19 (38.0)27 (54.0)0.160
COPD16 (32.0)16 (32.0)1.00
eGFR <60 ml/min31 (62.0)35 (70.0)0.527
STS-PROM score (%)9.1±5.58.4±3.80.567
Frailty8 (16.0)9 (18.0)1.00
Severely calcified or porcelain aorta14 (28.0)16 (32.0)0.828
Mean aortic gradient (mm Hg)42.3±16.640.4±17.00.566
Aortic valve area (cm2)0.62±0.160.67±0.230.266
LVEF (%)55±1354±120.809
LVEF<406 (12.0)9 (18.0)0.579
SPAP (mm Hg)46±1343±130.403
Moderate/severe mitral regurgitation19 (38.0)14 (28.0)0.395
  • Values are mean±SD, n (%).

  • CABG, coronary artery bypass graft; COPD, chronic obstructive pulmonary disease; eGFR, estimated glomerularfiltration rate; LVEF, left ventricular ejection fraction; PAP, systolic pulmonary artery pressure; STS-PROM, Society of Thoracic Surgeons predicted risk of mortality.